Aaron Philip Mitchell

1.8k total citations
64 papers, 1.3k citations indexed

About

Aaron Philip Mitchell is a scholar working on Economics and Econometrics, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aaron Philip Mitchell has authored 64 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Economics and Econometrics, 18 papers in Pharmacology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aaron Philip Mitchell's work include Health Systems, Economic Evaluations, Quality of Life (30 papers), Economic and Financial Impacts of Cancer (27 papers) and Pharmaceutical Economics and Policy (20 papers). Aaron Philip Mitchell is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (30 papers), Economic and Financial Impacts of Cancer (27 papers) and Pharmaceutical Economics and Policy (20 papers). Aaron Philip Mitchell collaborates with scholars based in United States, United Kingdom and Israel. Aaron Philip Mitchell's co-authors include Stacie B. Dusetzina, Ethan Basch, Alan B. Frey, George Miller, Junaid Ibrahim, Aaron N. Winn, Joel L. Rosenbaum, George B. Witman, Kaiyao Huang and Dennis R. Diener and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Aaron Philip Mitchell

58 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron Philip Mitchell United States 15 406 312 214 188 175 64 1.3k
Valderílio Feijó Azevedo Brazil 22 263 0.6× 69 0.2× 194 0.9× 921 4.9× 165 0.9× 116 1.8k
W. David Dotson United States 23 230 0.6× 106 0.3× 339 1.6× 44 0.2× 69 0.4× 34 1.7k
Nan Soon Wong Singapore 20 66 0.2× 163 0.5× 241 1.1× 28 0.1× 37 0.2× 39 1.1k
Ariadna Tibau Spain 17 345 0.8× 83 0.3× 190 0.9× 44 0.2× 27 0.2× 51 956
Nancy Roach United States 19 189 0.5× 20 0.1× 205 1.0× 32 0.2× 423 2.4× 35 1.7k
Gennaro Daniele Italy 24 171 0.4× 22 0.1× 559 2.6× 101 0.5× 170 1.0× 100 1.9k
Julie Dang United States 16 117 0.3× 11 0.0× 289 1.4× 104 0.6× 198 1.1× 38 1.2k
E. Claire Dees United States 19 23 0.1× 87 0.3× 575 2.7× 140 0.7× 129 0.7× 52 1.8k
Jane Bryce Italy 19 190 0.5× 16 0.1× 355 1.7× 83 0.4× 212 1.2× 41 1.8k
Chiledum Ahaghotu United States 21 69 0.2× 48 0.2× 330 1.5× 45 0.2× 37 0.2× 39 1.2k

Countries citing papers authored by Aaron Philip Mitchell

Since Specialization
Citations

This map shows the geographic impact of Aaron Philip Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Philip Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Philip Mitchell more than expected).

Fields of papers citing papers by Aaron Philip Mitchell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron Philip Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Philip Mitchell. The network helps show where Aaron Philip Mitchell may publish in the future.

Co-authorship network of co-authors of Aaron Philip Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron Philip Mitchell. A scholar is included among the top collaborators of Aaron Philip Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron Philip Mitchell. Aaron Philip Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mitchell, Aaron Philip, Stacie B. Dusetzina, Hannah E. Fuchs, et al.. (2025). Provider billing margin and cancer treatment selection: population based cohort study. BMJ. 391. e084729–e084729.
2.
Wang, Judy J., et al.. (2024). Cost trends in standard-of-care cancer treatments, 2017-2021.. Journal of Clinical Oncology. 42(16_suppl). 11073–11073. 1 indexed citations
3.
Mitchell, Aaron Philip, et al.. (2024). Trends in prices of checkpoint inhibitors in the US, 2016-2023.. Journal of Clinical Oncology. 42(16_suppl). 11075–11075.
4.
5.
Mitchell, Aaron Philip, et al.. (2024). Overlapping and non-overlapping indications for checkpoint inhibitors in the US.. Journal of Clinical Oncology. 42(16_suppl). 11057–11057. 14 indexed citations
6.
Mitchell, Aaron Philip, Hannah E. Fuchs, Prabal K. De, et al.. (2024). Quality of Treatment Selection for Medicare Beneficiaries With Cancer. Journal of Clinical Oncology. 43(5). 524–535. 3 indexed citations
7.
Jung, Jeah, et al.. (2024). Resource Use and Care Quality Differences Among Medicare Beneficiaries Undergoing Chemotherapy. JAMA Network Open. 7(9). e2434707–e2434707. 4 indexed citations
8.
Wallach, Joshua D., et al.. (2023). Clinical practice guideline descriptions of oncologic drugs granted FDA accelerated approval: A cross-sectional study.. Journal of Clinical Oncology. 41(16_suppl). 1590–1590. 2 indexed citations
9.
10.
Mitchell, Aaron Philip, et al.. (2022). Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases. 26(1). 126–132. 7 indexed citations
11.
Mitchell, Aaron Philip, et al.. (2021). Real-World Use of Bone-Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer. JNCI Journal of the National Cancer Institute. 114(3). 419–426. 15 indexed citations
12.
Mitchell, Aaron Philip, Michael Curry, Niti U. Trivedi, et al.. (2021). Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines. The Oncologist. 26(9). 771–778. 11 indexed citations
13.
Mitchell, Aaron Philip, et al.. (2020). The Accuracy and Usefulness of the National Comprehensive Cancer Network Evidence Blocks Affordability Rating. PharmacoEconomics. 38(7). 737–745. 5 indexed citations
14.
Wayant, Cole, Lisa Cosgrove, Elie A. Akl, et al.. (2020). Ten years later: a review of the US 2009 institute of medicine report on conflicts of interest and solutions for further reform. BMJ evidence-based medicine. 27(1). 46–54. 20 indexed citations
15.
Mitchell, Aaron Philip, Joel C. Boggan, Karen Lau, & David L. Simel. (2017). Splenectomy as a Destination: Improving Quality of Care Among Asplenic Veterans Through a Travel Clinic. The American Journal of Medicine. 130(7). 856–861. 8 indexed citations
16.
Mitchell, Aaron Philip, Bradford R. Hirsch, Michael R. Harrison, Amy P. Abernethy, & Daniel J. George. (2015). Deferred Systemic Therapy in Patients With Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer. 13(3). e159–e166. 13 indexed citations
17.
Nipp, Ryan David, Aaron Philip Mitchell, Allyson M. Pishko, & Ara Metjian. (2014). Waldenström Macroglobulinemia in Hepatitis C: Case Report and Review of the Current Literature. Case Reports in Oncological Medicine. 2014. 1–7. 5 indexed citations
18.
Mitchell, Aaron Philip, Bradford R. Hirsch, & Amy P. Abernethy. (2014). Lack of timely accrual information in oncology clinical trials: a cross-sectional analysis. Trials. 15(1). 92–92. 12 indexed citations
19.
Mitchell, Aaron Philip & Ross J. Simpson. (2012). Statin cost effectiveness in primary prevention: A systematic review of the recent cost-effectiveness literature in the United States. BMC Research Notes. 5(1). 373–373. 35 indexed citations
20.
Ibrahim, Junaid, Andrew H. Nguyen, Adeel ur Rehman, et al.. (2012). Dendritic Cell Populations With Different Concentrations of Lipid Regulate Tolerance and Immunity in Mouse and Human Liver. Gastroenterology. 143(4). 1061–1072. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valderílio Feijó Azevedo Breakdown of academic impact, for papers by W. David Dotson Breakdown of academic impact, for papers by Nan Soon Wong Breakdown of academic impact, for papers by Ariadna Tibau Breakdown of academic impact, for papers by Nancy Roach Breakdown of academic impact, for papers by Gennaro Daniele Breakdown of academic impact, for papers by Julie Dang Breakdown of academic impact, for papers by E. Claire Dees Breakdown of academic impact, for papers by Jane Bryce Breakdown of academic impact, for papers by Chiledum Ahaghotu
Rankless by CCL
2026